Description: MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.
Home Page: www.mph-ag.de
GrUenauer Strasse 5
Berlin,
12557
Germany
Phone:
49 30 863 214 560
Officers
| Name | Title |
|---|---|
| Mr. Patrick Brenske | CEO & Member of Management Board |
Exchange: XETRA
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3273 |
| Price-to-Sales TTM: | 11.9745 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1 |